Holen Sie sich die Stockscreener-App
0.7714
0.39%
0.00299
Schlusskurs vom Vortag:
$0.7684
Offen:
$0.77
24-Stunden-Volumen:
8,966
Relative Volume:
0.00
Marktkapitalisierung:
$21.15M
Einnahmen:
$71.39M
Nettoeinkommen (Verlust:
$-28.60M
KGV:
-0.2063
EPS:
-3.74
Netto-Cashflow:
$-12.92M
1W Leistung:
+1.50%
1M Leistung:
-4.17%
6M Leistung:
-65.33%
1J Leistung:
-67.93%
1-Tages-Spanne:
$0.7601
$0.7799
1-Wochen-Bereich:
$0.7257
$0.80
52-Wochen-Spanne:
$0.7257
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Firmenname
Trinity Biotech Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TRIB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.7714 | 21.15M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
134.55 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.56 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
385.40 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.71 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.04 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-10-23 | Herabstufung | Craig Hallum | Buy → Hold |
| 2015-09-03 | Eingeleitet | Raymond James | Outperform |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2008-07-22 | Bestätigt | Roth Capital | Buy |
| 2008-03-17 | Bestätigt | Roth Capital | Buy |
| 2007-12-10 | Bestätigt | Roth Capital | Buy |
| 2007-10-26 | Bestätigt | Roth Capital | Buy |
Alle ansehen
Trinity Biotech Plc Adr Aktie (TRIB) Neueste Nachrichten
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech Plc ADR (TRIB) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Market Highlights: Xometry Inc (XMTR) Ends on a Low Note at 36.21 - The Dwinnex
Daily Progress: SiTime Corp (SITM) Drop -20.93, Closing at 176.32 - The Dwinnex
Trinity Biotech Plc ADR (TRIB) Shares Down Despite Recent Market Volatility - The News Heater
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com India
Trinity Biotech announces breakthrough in CGM technology - Investing.com India
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Trinity Biotech revises credit terms to boost liquidity - Investing.com India
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - GlobeNewswire Inc.
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech files to sell 0.65M American Depositary shares by selling shareholders - MSN
Earnings call: Trinity Biotech Q3 2024 shows steady growth, strategic moves - Investing.com
What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet
Trinity Biotech regains Nasdaq compliance - Investing.com India
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com
Trinity Biotech acquires Metabolomics Diagnostics - Investing.com
TRIB underperforms with a -14.67 decrease in share price - US Post News
Balance Sheet Breakdown: Trinity Biotech Plc ADR (TRIB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com India
North America Blood Testing Market Size & Outlook, 2030 - Grand View Research
Finanzdaten der Trinity Biotech Plc Adr-Aktie (TRIB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):